Investment firm Baird has announced the downgrade of Apellis Pharmaceuticals Inc. stock rating from "outperform" to "neutral"
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Meanwhile, the institution has significantly lowered its target stock price from $52 to $41.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
PRECIOUS-Gold lacklustre as higher-for-longer rate outlook weighs on sentiment
Reuters•2026/09/23 04:48
Novo Nordisk is open to upgrading its New York listing status.
智通财经•2026/09/23 04:36
Novo Nordisk considers upgrading its New York listing to boost its U.S. profile
智通财经•2026/09/23 04:21
Crypto prices
More
Bitcoin
BTC
$86,606.42
+1.58%
Ethereum
ETH
$2,759.62
+1.25%
Tether USDt
USDT
$0.9999
+0.00%
BNB
BNB
$791.34
+0.62%
XRP
XRP
$1.62
+6.74%
USDC
USDC
$1.0000
+0.00%
Solana
SOL
$118.68
+1.77%
TRON
TRX
$0.3439
-1.37%
Zcash
ZEC
$1,616.07
+8.83%
Hyperliquid
HYPE
$97.35
+3.92%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now